Skip to main content
Clinical Trials/NCT06147557
NCT06147557CompletedNot Applicable

Effect of Repeated Brief Passive Heat Therapy on Metabolism in Healthy Young Adults

Lithuanian Sports University1 site in 1 country25 target enrollmentStarted: October 1, 2020Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
25
Locations
1
Primary Endpoint
Change in insulin sensitivity

Study Overview

Brief Summary

The goal of this prospective interventional study is to examine if repeated brief hot stimuli affects glucose metabolism and substrate oxidation in young non-obese adults. Young adult participants were asked to participate in fourteen 5-min procedures involving whole body passive heating at 45°C water.

The main question it aims to answer is: "Does repeated brief noxious heat stimuli is sufficient to improve glucose tolerance, insulin sensitivity, and fat oxidation in young non-obese adults?"

Detailed Description

No studies yet addressed whether brief heat stimuli could be viable time-efficient alternative approach in order to improve glucose metabolism and fat oxidation. Consequently, we aimed to examine the ability of brief noxious heat stimuli to improve glucose tolerance, insulin sensitivity, and fat oxidation in young adults. Non-obese males and females completed fourteen 5-min sessions involving whole body passive heating at 45°C water. Changes in catecholamines, cytokines, substrate oxidation, resting energy expenditure, glucose tolerance and insulin response were assessed.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Prevention
Masking
None

Eligibility Criteria

Ages
18 Years to 35 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •healthy non-obese (BMI between 18.5 and 29.9 kg/m2) males and females;
  • •no diseases, or conditions that could be worsened by exposure to acute hot water and affect experimental variables;
  • •no participation in any excessive formal physical exercise or sports program, temperature manipulation program or exposure to extreme temperatures.

Exclusion Criteria

  • •obesity (BMI greater than 30 kg/m2);
  • •needle phobia;
  • •taking medication and/or dietary supplements that may affect experimental variables.

Arms & Interventions

Heat therapy

Experimental

14 heat sessions of whole-body immersed in a 45°C water bath for 5 minutes.

Intervention: Heat therapy (Procedure)

Outcomes

Primary Outcomes

Change in insulin sensitivity

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

Indices for insulin sensitivity/resistance assessment were computed using the homeostatic model assessment for insulin resistance, quantitative insulin-sensitivity check index (QUICKI), and the Matsuda insulin sensitivity index were calculated.

Change in resting energy expenditure (kcal/day)

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the resting energy expenditure (REE; kcal/day) was calculated by using the Weir equation: REE = (3.941(VO2) + 1.106(VCO2)) × 1440.

Changes in cytokines concentration (pg/mL)

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

The venous serum interleukin-6 and tumor necrosis factor alpha concentrations (in pg/mL) were measured using enzyme-linked immunosorbent assay kits and a Spark multimode microplate reader

Change in glucose concentration (mmol/L)

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

The venous glucose concentration (in mmol/L) was measured using a Glucocard X-mini plus meter.

Changes in catecholamines concentration (ng/mL)

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

The venous plasma adrenaline and noradrenaline concentrations (in ng/mL) were measured using enzyme-linked immunosorbent assay kits and a Spark multimode microplate reader

Change in fat oxidation (g/min)

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the carbohydrate oxidation (CARBox; g/min) was calculated by using the equation: CARBox = 4.55 × VCO2 - 3.21 × VO2

Change in insulin concentration (μIU/mL)

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

The venous serum insulin concentrations (in μIU/mL) were measured using enzyme-linked immunosorbent assay kits (Cat. No. E-EL-H2237, Elabscience, China) and a Spark multimode microplate reader (Tecan, Austria).

Change in substrate oxidation

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the respiratory quotient (RQ=VCO2/VO2) was computed to determine substrate utilisation.

Change in fat oxidation (g/min

Time Frame: Pre-condition, post-condition (after 14 days), and after 1 month recovery

Oxygen consumption (VO2) and carbon dioxide (VCO2) output on a breath-by breath basis using a stationary MetaLyzer® 3B spiroergometry system (Cortex Biophysik GmbH) was measured at rest, and the fat oxidation (FATox; g/min) was calculated by using the equation: FATox = 1.67 × VO2 - 1.67 × VCO2,

Secondary Outcomes

  • Change in fat mass (kg)(Pre-condition, post-condition (after 14 days), and after 1 month recovery)
  • Change in body mass (kg)(Pre-condition, post-condition (after 14 days), and after 1 month recovery)
  • Change in fat free mass (kg)(Pre-condition, post-condition (after 14 days), and after 1 month recovery)
  • Change in body mass index (kg/m2)(Pre-condition, post-condition (after 14 days), and after 1 month recovery)
  • Change in oxygen consumption and carbon dioxide output (mL/min)(Pre-condition, post-condition (after 14 days), and after 1 month recovery)
  • Change in fat mass (%)(Pre-condition, post-condition (after 14 days), and after 1 month recovery)
  • Change in fat free mass (%)(Pre-condition, post-condition (after 14 days), and after 1 month recovery)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials